Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Griffon (GFF) Hunter Fan Buyout to Add Vigor to CPP Segment

Published 01/25/2022, 10:30 PM
Updated 07/09/2023, 06:31 AM

Griffon (NYSE:GFF) Corporation GFF announced that it completed the acquisition of Memphis, TN-based Hunter Fan Company for $845 million. The company agreed to the transaction on Dec 20, 2021, and received antitrust clearances on Jan 13, 2022.

Notably, the buyout was executed by Griffon’s subsidiary, The AMES Companies, Inc. The seller in the transaction is MidOcean Partners.

Shares of Griffon increased 3.31% on Jan 24, ending the trading session on the day at $23.75.

Inside the Headlines

Hunter Fan is a leading manufacturer and supplier of residential ceiling fans as well as those suitable for industrial and commercial purposes. Its offerings include SureSpeed, SIMPLEconnect and WeatherMax fans. It also provides air purifiers, replacement filters, heaters, bath fans, humidifiers, standing fans and thermostats.

Griffon considers Hunter Fan to be a strategic fit and it expects the same to complement its existing fan businesses. Well-known brands offered by Griffon are True Temper, AMES and ClosetMaid. It also believes that Hunter Fan’s solid product offerings, experienced workforce, healthy e-commerce businesses, innovation capabilities, and strong customer base will be advantageous.

Griffon’s Consumer and Professional Products (CPP) segment now houses the operations of Hunter Fan. The CPP segment operates through AMES Companies and provides professional and consumer products related to landscaping, outdoor lifestyles, and home storage and organization. The segment’s revenues increased 8% year over year in fiscal 2021 (ended September 2021) and represented 54% of Griffon’s total revenues in the year.

Financial Impacts of Hunter Fan Buyout

For fiscal 2022 (ending September 2022), the Hunter Fan buyout is anticipated to immediately prove accretive to Griffon’s earnings and cash flow. The same is likely to boost Griffon’s revenues by $400 million, earnings before interest, tax, depreciation and amortization (“EBITDA”) by $90 million, and earnings by 50 cents per share in fiscal 2023 (ending September 2023).

The acquisition price of $845 million was funded through Griffon’s term-loan facility (contribution $800 million), available cash and revolving credit facility. The value of $845 million mirrors the 9.4XEBITDA of the first full year of the transaction completion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Buyout Activities of Three Other Players

We have discussed the buyout activities of three other players in the industry to which Griffon belongs.

Danaher Corporation (NYSE:DHR) DHR acquired Canada-based Vanrx Pharmasystems in February 2021, while Swift Biosciences was added to its portfolio in first-quarter 2021. In August 2021, Danaher acquired Aldevron.

The company is slated to report fourth-quarter 2021 results on Jan 27, before market open. With earnings beat recorded on all occasions, Danaher’s earnings surprise for the last four quarters is 24.05%, on average.

Carlisle Companies (NYSE:CSL) Incorporated CSL (OTC:CSLLY) acquired California-based Henry Company in September 2021.

The company will release fourth-quarter results on Feb 10, after market close. Carlisle’s results were better than expected in the last four quarters, with an earnings surprise of 38.89%, on average.

Honeywell International Inc (NASDAQ:HON). HON acquired Tempe, AZ-based US Digital Designs in December 2021. It also added Performix in September and Sparta Systems in April.

The company is slated to report fourth-quarter 2021 results on Feb 3, before market open. Honeywell delivered better-than-expected results in the last four quarters, with an earnings beat of 3.70%, on average.


Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer (NYSE:SAM) Company which shot up +143.0% in little more than 9 months and NVIDIA (NASDAQ:NVDA) which boomed +175.9% in one year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Free: See Our Top Stock and 4 Runners Up >>

Click to get this free report

Honeywell International Inc. (HON): Free Stock Analysis Report

Danaher Corporation (DHR): Free Stock Analysis Report

Carlisle Companies Incorporated (CSL): Free Stock Analysis Report

Griffon Corporation (GFF): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.